Share Price:

APNASPENAspen Pharmacare Hldgs116212171 (22.97%)

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion

Stephen Saad, Aspen Group Chief Executive

Aspen Holdings, through its wholly owned subsidiary Aspen Global Incorporated, has entered into binding agreements for the 100% sale of Aspen Asia Pacific (excluding China) for R26.5 billion.

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: